CenterBook Partners LP Purchases 2,259 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)

CenterBook Partners LP grew its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 20.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,577 shares of the biopharmaceutical company’s stock after acquiring an additional 2,259 shares during […]

Related Keywords

United States ,Dekabank Deutsche Girozentrale ,Davids Tierney ,Steve Miller ,Catalyst Pharmaceuticals Stock Performance ,News Ratings For Catalyst Pharmaceuticals Daily ,Catalyst Pharmaceuticals ,Financial Services Group Inc ,Nasdaq ,Catalyst Pharmaceuticals Inc ,Envestnet Asset Management Inc ,Securities Exchange Commission ,Navellier Associates Inc ,Quarter For Catalyst Pharmaceuticals ,Catalyst Pharmaceuticals Profile ,Centerbook Partners ,Free Report ,Book Partners ,Asset Management ,Services Group ,Bank Deutsche Girozentrale ,Exchange Commission ,Director David ,Visit Holdingschannel ,Catalyst Pharmaceuticals Daily ,Nasdaq Cprx ,Cprx ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,